Sorry, you need to enable JavaScript to visit this website.

14th Annual Pfizer Frontiers in Human Disease Symposium

The Role of Cilia in Biology and Medicine

May 4th & 5th 2022

The Pfizer Frontiers in Human Disease Symposium aims to address rapidly emerging areas of biomedical science and technology that will influence future development of novel therapeutics. This year’s topic,“The Role of Cilia in Biology and Medicine,” will be presented by widely recognized thought leaders who perform highly impactful research in the topic area.

Agenda

 

  • 9:15 a.m. – 9:30 a.m. ETLog in
    9:30 a.m. – 9:45 a.m. ET

    Welcome – Morris J. Birnbaum, MD, PhD
    Pfizer
    Senior Vice President, Internal Medicine Research Unit

    Opening Remarks – Peter Jackson, PhD
    Stanford University School of Medicine
    Professor of Microbiology and Immunology and of Pathology
     


    Session 1

    9:45 a.m. – 10:30 a.m. ETLukas Sommer, PhD 
    University of Zurich
    Professor, Medical Faculty and Faculty of Science
    “ The Role of Cilia in Tumorigenesis” | Abstract
    10:30 a.m. – 11:15 a.m.Jing Hughes, MD, PhD
    Washington University School of Medicine in St. Louis
    Associate Professor of Medicine, Division of Endocrinology, Metabolism & Lipid Research
    “Primary cilia in pancreatic islet function” | Abstract
    11:15 a.m. – 11:30 a.m. ETBreak
    11:30 a.m. – 12:15 a.m. ETGaia Pigino, PhD
    Human Technopole
    Associate Head of Structural Biology Research Center
    “Structural cell biology of cilia and intraflagellar transport” | Abstract
    12:15 a.m. – 1:00 p.m. ETBreakout Session: Group Networking/Office Hours with Session 1 speakers
    1:00 p.m. – 2:00 p.m. ETLunch


    Session 2

    2:00 p.m. – 2:45 p.m. ETRajat Rohatgi, MD, PhD
    Stanford University School of Medicine
    Associate Professor of Biochemistry and of Medicine (Oncology)
    “ Cholesterol accessibility at the ciliary membrane regulates Hedgehog signaling” | Abstract
    2:45 p.m. – 3:30 p.m. ETKen-Ichi Takemaru, PhD
    Stony Brook University
    Professor, Department of Pharmacological Sciences
    “Chibby Family Members and Their Regulators in Ciliogenesis and Ciliopathies” | Abstract
    3:30 p.m. – 3:35 p.m. ETClosing Remarks – Morris J. Birnbaum, M.D., Ph.D.
    Pfizer, SVP-Chief Scientific Officer, Internal Medicine Research Unit
    3:35 p.m. - 4:20 p.m. ETBreakout Session: Group Networking/Office Hours with Session 2 speakers
    4:20 p.m. ETEnd of Day 1
  • 9:15 a.m. – 9:30 a.m.Log in
    9:30 a.m. – 9:45 a.m.

    Welcome – Morris J. Birnbaum, MD, PhD
    Pfizer
    Senior Vice President, Internal Medicine Research Unit

    Opening Remarks – Mikael Dolsten, MD, PhD
    Pfizer
    Chief Scientific Officer, President, Worldwide Research, Development and Medical

    Session 3

    9:45 a.m. – 10:30 a.mPleasantine Mill, PhD
    University of Edinburgh
    Group Leader, MRC Human Genetics Unit, Institute of Genetics and Cancer
    “Cilia in Development and Disease: Dynamics, Diversity and Reversing Disease Phenotypes” | Abstract
    10:30 a.m. – 11:15 a.m.Bradley Yoder, PhD
    University of Alabama
    Professor / Chairperson, Cell, Developmental, and Integrative Biology
    “Cilia, injury, and cystic kidney diseases” | Abstract
    11:15 a.m. – 11:30 a.m.Break
    11:30 a.m. – 12:15 a.m.Cecilia Lo, PhD 
    University of Pittsburgh
    Distinguished Professor and F. Sargent Cheever Chair, Department of Developmental Biology
    “Cilia in the complex genetics of congenital heart disease” | Abstract
    12:15 a.m. – 1:00 a.m.Breakout Session: Group Networking/Office Hours with Session 3 speakers
    1:00 p.m. – 2:00 p.m.Lunch
      

    Session 4

    2:00pm-2:45pm ETDavid Clapham, MD, PhD
    Howard Hughes Medical Institute
    Janelia Group Leader
    “A serotonergic axon-cilium synapse drives nuclear signaling in the brain” | Abstract
    2:45pm-3:30pm ETPeter Jackson, PhD
    Stanford University School of Medicine
    Professor of Microbiology and Immunology (Baxter Labs) and of Pathology
    “Ciliary Control of Metabolic Signaling” | Abstract
    3:30pm-3:35pm ETClosing Remarks - Morris J. Birnbaum, MD, PhD
    Pfizer, SVP-Chief Scientific Officer, Internal Medicine Research Unit
    3:35pm-4:20pm ETBreakout Session: Group Networking/Office Hours with Session 4 speakers
    4:20 ETEnd of Symposium

Hosts

Morrie_Headshot_300X170_0.jpg

CO-ORGAINIZER, Senior Vice President, Internal Medicine Research Unit, Pfizer

Mikael_Headshot_300X170_0.jpg

SPONSOR, Chief Scientific Officer and President, Worldwide Research, Development and Medical of Pfizer Inc.

Peter-Jackson_Headshot_300x170_0.jpg

CO-ORGAINIZER, Professor of Microbiology and Immunology (Baxter Labs) and of Pathology, Stanford University School of Medicine

Speakers